The interest in bioactive peptides as agents for the control of hypertension continues to increase and our previous study has confirmed that rapeseed protein-derived peptides (Thr-Phe, Leu-Tyr and Arg-Ala-Leu-Pro) possess dual in vitro inhibitions of renin and ACE activities [8]. The gene discussed is REN; the disease is hypertensive disorder.